- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04343924
Clinical Study About the Effects of Scuba Diving on Post Traumatic Stress Disorder (PTSD) (DIVE4NICE)
Clinical Study: Physiological Effects of Scuba Diving on PTSD by Activating the Parasympathetic System and Restoring the Optimal and Sustainable State of Balance Between the Sympathetic and Parasympathetic Autonomous Nervous System (Sympatho-vagale Scale)
Post-traumatic stress disorder (PTSD) is a set of symptoms that can be developed as a result of exposure to a traumatic event or events that can range in prevalence from 25% to 75%. While therapeutic management combines psychotherapy, drug therapy and social support, some PTSD remain resistant after early and appropriate initial treatment. In terms of physiopathology, several studies have shown that parasympathetic activity is significantly decreased in patients with PTSD. In scuba diving, the cardio-vascular stresses associated with submersion of the subject and the lungs due to breathing in a regulator are at the origin of a reflex activation of the parasympathetic nervous system. The objective is to study the effects of the scuba diving activities-induced autonomic parasympathetic nervous system activation on the symptomatic progression of patients with PTSD.
The study population will consist of patients monitored and treated for PTSD following the attacks of 14/07/2016 in Nice (France).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A group will be composed of patients (n=12) who will complete a Scuba Diving Discovery Course (GP+ Diving Group). This course, lasting 2 weeks, will consist of a daily dive, 5 days per week, for a total of 10 dives. These will be supervised by a graduate instructor according to the rules of supervision defined by the sport code. The dives will be conducted in open air, at a maximum depth of 6 meters for a maximum duration of 20 minutes.
A matched group (gender, age, height, weight and BMI) will be composed of patients (n=12) who will not complete the Scuba Diving Discovery Course (GP- Virtual reality group). The subjects of this group will follow virtual reality sessions recreating the environment in which the scuba divers of the GP+ group operate. A control group (GT) will be composed of patients (n=12) who are monitored and treated for PTSD and who will not attend the dive discovery course or virtual reality sessions.
- The main evaluation criterion will be the NON-INVASIVE determination of salivary alpha amylase.
- Secondary evaluation criteria will be heart rate variation, CGI, HAD and BECK Anxiety, EGF, PCL-S and IES questionary.
The main objective is to study the effects of immersion and pressure relief ventilation on the activation of the autonomic parasympathetic nervous system.
Secondary objectives are to assess the symptomatic impact of parasympathetic autonomic nervous system activation on overall improvement, anxiety and depressive symptoms, functioning, and the 3 subtypes of PTSD symptoms as vegetative neuro hyperactivity, invasive syndrome and avoiding
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nice, France, 06000
- Chu De Nice
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult patients
- Patients who understand and read French
- Patients who have signed the informed consent form
- Patients who have never practiced scuba diving
- Patients medically fit for scuba diving
- Patients with the DSM-5 criteria for Post-traumatic Stress Disorder
- PCL-S score strictly greater than 44
- CGI greater than or equal to 4
- Chronicity (duration greater than 3 months)
Exclusion Criteria:
- Women of reproductive age without contraception
- Pregnant or nursing women
- Patients under guardianship or curatorship and detainees of justice
- Patients who previously practised scuba diving or hold a diving certificate
- Patients whose medical condition medically contraindicated the practice of scuba diving,
- Patients having a water phobia, bipolar or psychotic disorder
- Patients with a severe and proven suicidal risk (MINI-S and medical examination)
- Patients treated for less than 2 months with antidepressants;
- Patients treated for less than 2 months with specific psychotherapy (Cognitive and Behavioural Therapy, EMDR)
- Patients with response to treatment (50% decrease in symptoms)
- Contraindications to the practice of virtual reality.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Diving Group
The subjects of this group daily dive, 5 days per week, for a total of 10 dives at a maximum depth of 6 meters for a maximum duration of 20 minutes in a swimming pool.
|
The subjects of this group daily dive, 5 days per week, for a total of 10 dives at a maximum depth of 6 meters for a maximum duration of 20 minutes in a swimming pool.
|
|
Active Comparator: Virtual reality Group
The subjects of this group will follow virtual reality sessions recreating the environment in which the submarine diver of the GP+ group operates.
|
The subjects of this group will follow virtual reality sessions recreating the environment in which the submarine diver of the GP+ group operates
|
|
No Intervention: Control Group
The subjects of this group will be monitored and treated for PTSD and will not attend the dive discovery course or virtual reality sessions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The main objective is to study the physiological effects of pressure regulator immersion
Time Frame: 6 months
|
Measure of parterial pressure
|
6 months
|
|
The main objective is to study the physiological effects of regulator ventilation on the activation of the parasympathetic autonomic nervous system
Time Frame: 6 months
|
Measure of O2 saturation
|
6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Carl WILLEM, Centre Hospitalier Universitaire De Nice
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-PP-12
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.